Clinical trial
Circulating DNA to Improve Outcome of Oncology PatiEnt: A Randomized Study - COPE Study
NCT04258137 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating DNA to Improve Outcome of Oncology PatiEnt: A Randomized Study - COPE Study
- Lead sponsor
- Institut Bergonié
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 4, 2020
- Completion date
- December 1, 2027
- Enrollment
- 332 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer, non small cell lung cancer